krystal-1: activity of adagrasib in krasg12m nsclc with untreated cns metastases
Published 2 years ago • 325 plays • Length 3:17Download video MP4
Download video MP3
Similar videos
-
1:18
krystal-1: adagrasib in nsclc patients with cns metastases
-
1:22
krystal-1: activity and safety of adagrasib in patients with advanced/metastatic krasg12cm nsclc
-
2:54
krystal-1: adagrasib for kras-mutant nsclc
-
4:35
adagrasib shows cns penetration and encouraging intracranial activity for krasg12c-mutated nsclc
-
1:08
how will adagrasib fit into the treatment landscape of krasg12-mutant nsclc?
-
3:48
krystal-1: adagrasib as monotherapy or combined with cetuximab in patients with crc harboring a ...
-
1:10
current treatment strategies krasg12c–mutated nsclc
-
1:00
krystal-1: next steps in the field of krasg12c-mutant cancers
-
1:26
krystal-1 and codebreak 100: targeting kras g12c in lung cancer
-
2:40
krystal 7 study: adagrasib /- pembrolizumab for kras g12c nsclc -targeted therapies in lung cancer
-
2:51
#esmo21 highlights on adagrasib in patients with krasg12c-mutated crc: the krystal-1 study
-
0:58
challenges and treatment of cns metastases in nsclc
-
1:07
metis: tumor treating fields (ttfields) in patients with nsclc and brain metastases
-
4:37
treatment options for brain metastases in nsclc
-
3:16
predicting the development of brain metastases in patients with radically treated stage iii nsclc
-
1:01
krystal-1: adagrasib with cetuximab in kras g12c-mutated crc
-
0:40
areas of unmet need for patients with nsclc and brain metastases
-
5:16
immunotherapy and brain metastatic lung cancer
-
1:12
overcoming resistance to kras g12c inhibitors in nsclc